Page last updated: 2024-09-05

erlotinib hydrochloride and Experimental Lung Inflammation

erlotinib hydrochloride has been researched along with Experimental Lung Inflammation in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Duan, Y; Liao, XY; Sun, J; Wang, Y; Xu, Z; Yang, Q; Zheng, L; Zhu, B; Zhu, G	1
Chen, TC; Lee, KM; Lien, CT; Lin, SY; Lu, PL	1
Geyer, AI; Kelly, DW; O'Reilly, EM; Sahin, IH	1
Chu, JG; Li, GX; Qian, GQ; Yin, FY	1
Hammersley, JR; Kanjwal, S; Taj, A	1
Chang, FT; Kung, YC; Liaw, SF; Lin, CC; Lin, MW	1
Chowbay, B; Goh, JW; Lee, P; Mancer, K; Tan, PH; Toh, CK	1
Esmaili, A; Vahid, B	1

Trials

1 trial(s) available for erlotinib hydrochloride and Experimental Lung Inflammation

Article	Year
Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations. The oncologist, 2019, Volume: 24, Issue:8 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Female; Follow-Up Studies; Gefitinib; Glucocorticoids; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonia; Progression-Free Survival; Protein Kinase Inhibitors; Radiation Injuries	2019

Article

Year

Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations.

The oncologist, 2019, Volume: 24, Issue:8

Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Female; Follow-Up Studies; Gefitinib; Glucocorticoids; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonia; Progression-Free Survival; Protein Kinase Inhibitors; Radiation Injuries

2019

Other Studies

7 other study(ies) available for erlotinib hydrochloride and Experimental Lung Inflammation

Article	Year
A swollen knee in a 77-year-old lung cancer patient receiving antimicrobial therapy for pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:12 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Erlotinib Hydrochloride; Fatal Outcome; Humans; Knee; Knee Injuries; Lung Neoplasms; Male; Pneumonia; Quinazolines	2013
Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications. Clinical colorectal cancer, 2016, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Alcohol-Related Disorders; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cohort Studies; Deoxycytidine; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Peritoneal Neoplasms; Pneumonia; Retrospective Studies; Risk Factors; Severity of Illness Index; Smoking	2016
Hepatoid adenocarcinoma of the lung. QJM : monthly journal of the Association of Physicians, 2016, Volume: 109, Issue:9 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Erlotinib Hydrochloride; Fatal Outcome; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Pneumonia; Tomography, X-Ray Computed	2016
New-onset acute interstitial lung disease after treatment with erlotinib in a patient with metastatic squamous cell carcinoma of the lung. American journal of therapeutics, 2011, Volume: 18, Issue:1 Topics: Aged; Biopsy; Brain Neoplasms; Carcinoma, Squamous Cell; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Pneumonia; Quinazolines; Tomography, X-Ray Computed	2011
Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats. Respiratory physiology & neurobiology, 2011, Mar-15, Volume: 175, Issue:3 Topics: Airway Remodeling; Allergens; Animals; Bronchial Hyperreactivity; Erlotinib Hydrochloride; Immunohistochemistry; Ovalbumin; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred BN; Reverse Transcriptase Polymerase Chain Reaction	2011
An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer. Acta oncologica (Stockholm, Sweden), 2007, Volume: 46, Issue:2 Topics: Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Pleural Effusion; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Radiography; Treatment Outcome	2007
Erlotinib-associated acute pneumonitis: report of two cases. Canadian respiratory journal, 2007, Volume: 14, Issue:3 Topics: Acute Disease; Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Glucocorticoids; Humans; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonia; Protein Kinase Inhibitors; Quinazolines; Shock, Septic	2007